Model-based Prediction of the Long-term Glucose-Lowering Effects of Ipragliflozin, a Selective Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor, in Patients with Type 2 Diabetes Mellitus

INTRODUCTION: Sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors inhibit the reabsorption of glucose from the kidneys and increase urinary glucose excretion (UGE), thereby lowering the blood glucose concentration in people suffering from type 1 and type 2 diabetes mellitus (T2DM). In a prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Masako, Kaibara, Atsunori, Kadokura, Takeshi, Toyoshima, Junko, Yoshida, Satoshi, Kazuta, Kenichi, Ueyama, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136367/
https://www.ncbi.nlm.nih.gov/pubmed/32166619
http://dx.doi.org/10.1007/s13300-020-00785-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136367/
https://www.ncbi.nlm.nih.gov/pubmed/32166619
http://dx.doi.org/10.1007/s13300-020-00785-2

Ejemplares similares